(PharmaNewsWire.Com, August 11, 2021 ) The Key Growth Elements in Detailed?
Cold plasma technology has diverse applications in several industries. This processing method possessesmany advantages, such as low water and energy consumption, minimal fiber damage, reduced flammability, low chemical consumption, improved wettability, low cost, and a worker-friendly nature. Also, cold plasma technologies do not require onsite storage of supply chemicals or large volumes of processing water, either for implementation or in post-treatment rinsing. Their benefits, as compared to the currently used alternatives in application industries, have served to drive the adoption of cold plasma techniques.
Worldwide Growth Opportunities in Terms of Revenue:
The global cold plasma market size is projected to reach USD 3.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 16.0%.
Opportunity Application of cold plasma in infection prevention and prolonging the life of PPE;
Cold plasma can be used in the prevention of infectious diseases and nosocomial infections as it kills highly stable multi-resistant microbes. In the COVID-19 pandemic, protective clothing and sterile textiles are in short supply. Treatment with cold plasma or ozone-generating plasma can prolong the use of clothing. It can also help in the hydrophilization process in the textile industry for gloves, PPE kits, and masks to reduce microorganisms. Plasmatreat, one of the leading players in the cold plasma market, has developed a prototype cleaning station that provides solutions for disinfecting protective clothing.
Low-pressure cold plasma to witness the highest growth during the forecast period.
Based on the regime, the cold plasma market is classified broadly into atmospheric cold plasma and low-pressure plasma. The low-pressure cold plasma is estimated to hold the largest share of the market in 2019 and is also projected to grow at the highest rate during the forecast period. The large share and high growth rate of this segment can be attributed to the bactericidal activity and minimal surface ablation.
The Europe is expected to account for the largest share of the cold plasma market in 2019, followed by North America. The large share of Europe in the global market can be attributed to the presence of a large number of cold plasma companies and growing R&D work in Germany.
The Asia Pacific region is expected to register the highest growth during the forecast period, primarily due to the growing demand for cold plasma technology in China, India, Japan, and South Korea, among other APAC countries. Considering this factor, a majority of global companies are focusing on developing and expanding their R&D capabilities and distribution networks in this region.
Major Key Players Mentioned in the research report are:
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
